Cboe AU - Delayed Quote AUD

Micro-X Limited (MX1.XA)

Compare
0.0630 -0.0050 (-7.35%)
At close: November 22 at 3:41 PM GMT+11
Loading Chart for MX1.XA
DELL
  • Previous Close 0.0680
  • Open 0.0630
  • Bid 0.0560 x --
  • Ask --
  • Day's Range 0.0630 - 0.0630
  • 52 Week Range 0.0510 - 0.1400
  • Volume 37,705
  • Avg. Volume 92,476
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.63
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0420
  • Earnings Date Aug 29, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Micro-X Limited designs, develops, manufactures, and commercializes healthcare and security markets products using micro-X proprietary cold cathode X-ray technology in Australia, the United States, Asia-Pacific, Europe, the Middle East, and Africa. The company offers carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components. It also provides Rover Plus for full medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; ARGUS for transforming stand-off imaging; Checkpoints, a modular passenger self-screening checkpoint for airports; and Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints. Micro-X Limited was incorporated in 2011 and is based in Tonsley, Australia.

www.micro-x.com

--

Full Time Employees

June 30

Fiscal Year Ends

--

Sector

--

Industry

Recent News: MX1.XA

View More

Performance Overview: MX1.XA

Trailing total returns as of 11/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MX1.XA
37.00%
MSCI WORLD
18.83%

1-Year Return

MX1.XA
49.60%
MSCI WORLD
25.33%

3-Year Return

MX1.XA
78.64%
MSCI WORLD
17.63%

5-Year Return

MX1.XA
73.19%
MSCI WORLD
65.62%

Compare To: MX1.XA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MX1.XA

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -64.15%

  • Return on Assets (ttm)

    -35.53%

  • Return on Equity (ttm)

    -62.09%

  • Revenue (ttm)

    15.22M

  • Net Income Avi to Common (ttm)

    -9.77M

  • Diluted EPS (ttm)

    -0.0420

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.23M

  • Total Debt/Equity (mrq)

    27.98%

  • Levered Free Cash Flow (ttm)

    -7.17M

Research Analysis: MX1.XA

View More

Company Insights: MX1.XA

Research Reports: MX1.XA

View More